Memorializing Governor Kathy Hochul to proclaim March 2026, as Autoimmune Awareness Month in the State of New York
Summary
This resolution memorializes Governor Kathy Hochul to proclaim March 2026 as Autoimmune Awareness Month in New York State, in conjunction with National Autoimmune Awareness Month. It is a nonbinding commemorative measure that expresses the Legislature’s support for public awareness of autoimmune diseases and directs that copies of the resolution be sent to the Governor and the Autoimmune Association.
The resolution describes autoimmune diseases as a broad category of more than 140 chronic conditions that can affect multiple body systems, are often difficult to diagnose, and can lead to serious disability or death. It cites research and advocacy findings about the prevalence, cost, and diagnostic delays associated with autoimmune disease, and argues that a designated awareness month would help educate the public and encourage research funding, earlier diagnosis, and better treatment.
Impact
Because this is a memorializing resolution rather than a bill creating or amending statutory law, it does not change the New York Consolidated Laws or impose legal duties on state agencies, health providers, or private parties. Its practical effect is symbolic and promotional: it seeks a gubernatorial proclamation and aims to elevate public attention to autoimmune disease, potentially supporting advocacy for research, education, and patient awareness.
Sentiment
The overall sentiment reflected in the resolution is strongly supportive and sympathetic toward individuals living with autoimmune diseases. The text emphasizes the seriousness of these conditions, the burden on patients and families, and the need for greater awareness, research, and earlier diagnosis. No opposing views, amendments, or negative votes are provided in the available record, and the measure appears to be presented as a consensus public-awareness resolution.
Contention
No direct contention is shown in the bill text, voting history, or committee materials provided. The only implied policy tension is between symbolic awareness measures and the broader need for substantive action on research funding, diagnostic standards, and treatment access; however, no legislator, committee member, or stakeholder is identified as opposing the resolution. The resolution itself frames the issue as one of under-recognition and unmet medical need rather than partisan disagreement.
Supporting the designation of March as "Autoimmune Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research.
Human services: medical services; coverage for the prophylaxis, diagnosis, and treatment of certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1939 PA 280 (MCL 400.1 - 400.119b) by adding sec. 109v.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.